104 related articles for article (PubMed ID: 24788530)
1. Immunohistochemical analysis of expressions of RB1, CDK4, HSP90, cPLA2G4A, and CHMP2B is helpful in distinction between myxofibrosarcoma and myxoid liposarcoma.
Wang T; Goodman MA; McGough RL; Weiss KR; Rao UN
Int J Surg Pathol; 2014 Oct; 22(7):589-99. PubMed ID: 24788530
[TBL] [Abstract][Full Text] [Related]
2. Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity.
Willems SM; van Remoortere A; van Zeijl R; Deelder AM; McDonnell LA; Hogendoorn PC
J Pathol; 2010 Dec; 222(4):400-9. PubMed ID: 20839361
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of NCOA2 fluorescence in situ hybridization and Stat6 immunohistochemistry staining for soft tissue angiofibroma and morphologically similar fibrovascular tumors.
Sugita S; Aoyama T; Kondo K; Keira Y; Ogino J; Nakanishi K; Kaya M; Emori M; Tsukahara T; Nakajima H; Takagi M; Hasegawa T
Hum Pathol; 2014 Aug; 45(8):1588-96. PubMed ID: 24856853
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis.
Meis-Kindblom JM; Sjögren H; Kindblom LG; Peydró-Mellquist A; Röijer E; Aman P; Stenman G
Virchows Arch; 2001 Aug; 439(2):141-51. PubMed ID: 11561754
[TBL] [Abstract][Full Text] [Related]
5. Paratesticular dedifferentiated liposarcoma with prominent myxoid stroma: report of a case and review of the literature.
Tajima S; Koda K
Med Mol Morphol; 2017 Jun; 50(2):112-116. PubMed ID: 25986682
[TBL] [Abstract][Full Text] [Related]
6. Extensive lipoma-like changes of myxoid liposarcoma: morphologic, immunohistochemical, and molecular cytogenetic analyses.
Iwasaki H; Ishiguro M; Nishio J; Aoki M; Yokoyama R; Yokoyama K; Taguchi K; Nabeshima K
Virchows Arch; 2015 Apr; 466(4):453-64. PubMed ID: 25650275
[TBL] [Abstract][Full Text] [Related]
7. NY-ESO-1 is a sensitive and specific immunohistochemical marker for myxoid and round cell liposarcomas among related mesenchymal myxoid neoplasms.
Hemminger JA; Iwenofu OH
Mod Pathol; 2013 Sep; 26(9):1204-10. PubMed ID: 23599152
[TBL] [Abstract][Full Text] [Related]
8. [Myxoid tumors of deep soft tissues].
Labonté S
Ann Pathol; 2015 Jan; 35(1):3-14. PubMed ID: 25533917
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of p16 in lipoblastomas.
Cappellesso R; d'Amore ES; Dall'Igna P; Guzzardo V; Vassarotto E; Rugge M; Alaggio R
Hum Pathol; 2016 Jan; 47(1):64-9. PubMed ID: 26514741
[TBL] [Abstract][Full Text] [Related]
10. DDIT3 gene break-apart as a molecular marker for diagnosis of myxoid liposarcoma--assay validation and clinical experience.
Narendra S; Valente A; Tull J; Zhang S
Diagn Mol Pathol; 2011 Dec; 20(4):218-24. PubMed ID: 22089349
[TBL] [Abstract][Full Text] [Related]
11. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms.
Downs-Kelly E; Goldblum JR; Patel RM; Weiss SW; Folpe AL; Mertens F; Hartke M; Tubbs RR; Skacel M
Am J Surg Pathol; 2008 Jan; 32(1):8-13. PubMed ID: 18162764
[TBL] [Abstract][Full Text] [Related]
12. Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma.
Dei Tos AP; Piccinin S; Doglioni C; Vukosavljevic T; Mentzel T; Boiocchi M; Fletcher CD
Am J Pathol; 1997 Dec; 151(6):1531-9. PubMed ID: 9403703
[TBL] [Abstract][Full Text] [Related]
13. Myxofibrosarcoma: cytomorphologic findings and differential diagnosis on fine needle aspiration.
Olson MT; Ali SZ
Acta Cytol; 2012; 56(1):15-24. PubMed ID: 22236741
[TBL] [Abstract][Full Text] [Related]
14. Myxoid and round cell liposarcoma: a spectrum of myxoid adipocytic neoplasia.
Orvieto E; Furlanetto A; Laurino L; Dei Tos AP
Semin Diagn Pathol; 2001 Nov; 18(4):267-73. PubMed ID: 11757867
[TBL] [Abstract][Full Text] [Related]
15. Fibrosarcoma-like lipomatous neoplasm: a reappraisal of so-called spindle cell liposarcoma defining a unique lipomatous tumor unrelated to other liposarcomas.
Deyrup AT; Chibon F; Guillou L; Lagarde P; Coindre JM; Weiss SW
Am J Surg Pathol; 2013 Sep; 37(9):1373-8. PubMed ID: 23887155
[TBL] [Abstract][Full Text] [Related]
16. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
[TBL] [Abstract][Full Text] [Related]
17. Liposarcoma of the extremities: MR imaging features and their correlation with pathologic data.
El Ouni F; Jemni H; Trabelsi A; Ben Maitig M; Arifa N; Ben Rhouma K; Ben Ayech M; Tlili K
Orthop Traumatol Surg Res; 2010 Dec; 96(8):876-83. PubMed ID: 20934400
[TBL] [Abstract][Full Text] [Related]
18. Benign recurring lipoblastoma in an adult versus well differentiated subcutaneous myxoid liposarcoma: clinicopathologic, immunohistochemical and molecular analysis of a unique case.
Silverman JS; Hamilton J; Tamsen A
Pathol Res Pract; 1999; 195(11):787-92; discussion 793. PubMed ID: 10605700
[TBL] [Abstract][Full Text] [Related]
19. Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.
Cheng H; Dodge J; Mehl E; Liu S; Poulin N; van de Rijn M; Nielsen TO
Hum Pathol; 2009 Sep; 40(9):1244-51. PubMed ID: 19368956
[TBL] [Abstract][Full Text] [Related]
20. Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases.
Nascimento AF; Bertoni F; Fletcher CD
Am J Surg Pathol; 2007 Jan; 31(1):99-105. PubMed ID: 17197925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
